Prospan

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

Hedera helix, Quantity: 7 mg/mL (Equivalent: Hedera helix, Qty 43.75 mg/mL; Equivalent: emetine, Qty 0 mg/mL)

Verfügbar ab:

SFI Australasia

INN (Internationale Bezeichnung):

Hedera helix

Darreichungsform:

Oral Liquid

Zusammensetzung:

Excipient Ingredients: potassium sorbate; sorbitol solution (70 per cent) (crystallising); purified water; xanthan gum; citric acid; Flavour

Verabreichungsweg:

Oral

Anwendungsgebiete:

Anti-inflammatory/relieve inflammation ; Decrease/reduce/relieve mild bronchial irritation ; Decrease/reduce/relieve bronchial mucous congestion ; Soothe/calm the chest ; Decrease/reduce excess chest phlegm ; Loosen chest phlegm ; Decrease/reduce excess mucous ; Decrease/reduce/relieve mild upper respiratory tract congestion ; Expectorant/clear respiratory tract mucous ; Loosen respiratory tract mucous ; Decrease/reduce/relieve mild bronchial cough ; Decrease/reduce/relieve cough ; Enhance/improve/promote/increase cough productivity ; Soothe respiratory tract mucous membranes/mucous tissue

Produktbesonderheiten:

Visual Identification: ;

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-09-16